Usefulness of the CONUT Index Upon Hospital Admission as a Potential Prognostic Indicator of COVID-19 Health Outcomes
The COVID-19 pandemic has placed unprecedented strain on global healthcare systems, underscoring the urgent need for reliable prognostic tools to identify high-risk patients early in their clinical course. Nutritional status, a modifiable risk factor, has gained attention as a predictor of outcomes in acute and chronic illnesses. The Controlling Nutritional Status (CONUT) index, a composite score derived from serum albumin, cholesterol, and lymphocyte counts, has shown promise in predicting morbidity and mortality in various diseases. This study evaluates the utility of the CONUT index upon hospital admission as a prognostic indicator for COVID-19 outcomes, including mortality, length of hospitalization, and resource utilization.
Background and Rationale
COVID-19 exhibits heterogeneous clinical manifestations, ranging from asymptomatic infection to critical illness involving multi-organ failure. Early identification of patients at risk of severe outcomes is crucial for optimizing resource allocation and clinical management. Traditional prognostic markers, such as age and comorbidities, lack specificity, while complex scoring systems may be impractical in overwhelmed healthcare settings. The CONUT index, validated in other conditions for detecting undernutrition and predicting complications, offers a simple, objective tool based on routine laboratory parameters. This study investigates whether CONUT scores at admission correlate with COVID-19 severity and mortality.
Study Design and Methodology
Cohort and Data Collection
A retrospective observational study was conducted at Hospital Universitario de La Princesa in Madrid, Spain, including 2,844 adult patients admitted with confirmed COVID-19 between February 5, 2020, and January 21, 2021. After excluding readmissions, 1,627 patients with complete data for CONUT calculation (albumin, cholesterol, and lymphocyte counts measured within four days of admission) were analyzed.
CONUT Index Calculation
The CONUT index categorizes patients into four risk stages:
- Normal (0–1): Albumin ≥3.5 g/dL, lymphocytes >1,600/μL, cholesterol >180 mg/dL.
- Light (2–4): Albumin 3.0–3.4 g/dL, lymphocytes 1,200–1,599/μL, cholesterol 140–180 mg/dL.
- Moderate (5–8): Albumin 2.5–2.9 g/dL, lymphocytes 800–1,199/μL, cholesterol 100–139 mg/dL.
- Severe (9–12): Albumin <2.5 g/dL, lymphocytes <800/μL, cholesterol <100 mg/dL.
Outcomes and Statistical Analysis
Primary outcomes included 30-day mortality, length of hospitalization, and requirements for non-invasive (NIMV) or invasive mechanical ventilation (IMV). Secondary outcomes encompassed admission to intermediate respiratory care units (IRCU) and intensive care units (ICU). Statistical methods included Kaplan-Meier survival analysis, Cox proportional hazards regression, and receiver operating characteristic (ROC) curve analysis.
Key Findings
Patient Characteristics
The cohort had a mean age of 67.3 ± 16.5 years, with 44.9% female participants. CONUT stage distribution was:
- Normal: 11.9% (n=194)
- Light: 47.2% (n=769)
- Moderate: 35.9% (n=585)
- Severe: 4.9% (n=79)
Aging correlated with higher CONUT scores: patients with severe CONUT had a mean age of 79.1 ± 11.0 years versus 59.7 ± 16.1 years in the normal group (P<0.001). Males exhibited higher CONUT stages than females (P<0.001).
Mortality and Survival Analysis
Thirty-day mortality escalated significantly with worsening CONUT stage:
- Normal: 3.1%
- Light: 9.0%
- Moderate: 22.7%
- Severe: 40.5%
Kaplan-Meier curves demonstrated stark survival disparities, with severe CONUT patients experiencing rapid decline within the first three days of admission (log-rank P<0.001). Multivariable Cox regression confirmed CONUT as an independent mortality predictor:
- Moderate vs. Normal: Hazard ratio (HR)=2.61 (95% CI:1.14–5.95; P=0.023)
- Severe vs. Normal: HR=2.77 (95% CI:1.14–6.73; P=0.024)
Hospitalization and Resource Utilization
Higher CONUT scores correlated with prolonged hospitalization:
- Normal: 7.9 ± 9.2 days
- Severe: 22.1 ± 25.2 days (P<0.001)
Resource demands surged with CONUT severity:
- NIMV Use: 2.6% (normal) vs. 10.1% (severe; P<0.001)
- IMV Use: 1.0% (normal) vs. 19.0% (severe; P<0.001)
- ICU Admission: 2.5% (normal) vs. 20.2% (severe; P<0.001)
Predictive Accuracy
ROC analysis yielded an area under the curve (AUC) of 0.711 (95% CI:0.676–0.746), indicating moderate discriminative power for mortality prediction.
Discussion
Clinical Implications
The CONUT index effectively stratifies COVID-19 patients by mortality risk and healthcare resource needs at admission. Its components—albumin, cholesterol, and lymphocytes—reflect systemic inflammation, nutritional deficits, and immune dysfunction, all implicated in COVID-19 pathogenesis. Hypoalbuminemia, a marker of malnutrition and capillary leakage, may exacerbate organ dysfunction. Lymphopenia, a hallmark of severe COVID-19, correlates with impaired viral clearance, while hypocholesterolemia signals hepatic stress and cytokine-driven lipid metabolism alterations.
Strengths and Limitations
This large cohort study underscores CONUT’s practicality in real-world settings, using routinely available lab data. However, 42.8% of admissions lacked CONUT parameters, primarily due to missing cholesterol measurements during pandemic surges. Manual retrieval of variables like BMI was incomplete, limiting nutritional status analysis. Additionally, the study’s retrospective design and single-center focus warrant validation in diverse populations.
Comparison with Existing Literature
Prior studies in cancers and chronic diseases support CONUT’s prognostic utility. In COVID-19, smaller cohorts have linked CONUT to mortality, but this study provides robust evidence through multivariable adjustment and detailed outcome stratification. The AUC of 0.711 aligns with other COVID-19 prognostic scores, balancing simplicity and accuracy.
Future Directions
Prospective studies should evaluate CONUT’s dynamic changes during hospitalization and their association with treatment response. Integrating CONUT with clinical parameters (e.g., oxygen saturation, comorbidities) may enhance predictive accuracy. Furthermore, interventional trials could assess whether nutritional optimization improves outcomes in high-CONUT patients.
Conclusion
The CONUT index at hospital admission is a reliable, independent predictor of mortality and resource utilization in COVID-19 patients. Its ease of calculation from routine labs makes it a practical tool for risk stratification, guiding clinical decision-making, and optimizing resource allocation during pandemic surges. Future research should validate these findings across diverse settings and explore interventions targeting modifiable CONUT components.
doi.org/10.1097/CM9.0000000000001798
Was this helpful?
0 / 0